The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...

It can improve motor symptoms, including tremors. Deep brain stimulation (DBS) will continue to see high usage in Parkinson’s ...

Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement ...

Parkinson’s UK has today (15 January) revealed updated branding, including a new logo and strapline, and a bespoke accessible ...

Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...

The lab of Professor Peter Vangheluwe at KU Leuven is collaborating with SandboxAQ, an AI company, to expedite the discovery and testing of candidate drugs to restore the function of ATP10B, a protein ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...